Overall Technical outlook

Price Summary

On 2025-12-10, Piramal Pharma Limited's stock started at 173.42, soared to 174.45, dropped to 170.1, and finished the day -1.4% down at 170.99, with a trading volume of 1935171 shares.
The stock's highest value over the last 52 weeks is 266.25, and the lowest value is 170.99.
PPLPHARMA's future price is expected to lie between 195.0 and 310.0, with an average expectation of 244.33333, as per the recommendations of 9 analysts.

Technicals


Aroon: The Aroon indicator is signaling a continued bearish trend, with Aroon Down holding steady at the 100 level. This persistent downward momentum warrants further analysis in conjunction with other indicators to determine its potential impact.
PPLPHARMA aroon 261565
Aroon chart for Piramal Pharma Limited


Bol. Bands: The price has fallen below the lower Bollinger Band, suggesting that the market might be experiencing oversold conditions. This move reflects increased selling pressure, driving prices to a significant low. The breach could either indicate a continuation of the downtrend or a possible reversal if traders start to see this as a buying opportunity at these depressed levels.
PPLPHARMA bbands 261565
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR continues to signal a bearish outlook, establishing a resistance level that could act as a ceiling for upward trends. This resistance suggests that the market may struggle to overcome bearish forces, keeping prices under pressure.
PPLPHARMA psar 261565
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The Stochastic K-line's descent below the D-line and under 20 suggests a mildly bearish outlook for PPLPHARMA. This indicates that the market may face some pressure to the downside, though the bearish tone is moderate. Investors should consider this as a potential early warning sign.
PPLPHARMA stoch 261565
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages suggests a bullish trend, but the slopes of the faster averages hint at a potential reversal. The weakening signals from these shorter-term averages indicate that the current upward momentum may be fading, suggesting that a change in direction could be near.
PPLPHARMA trippleSMA 261565
Tripple SMA chart for Piramal Pharma Limited


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.